B

BioCryst Pharmaceuticals
D

BCRX

8.94000
USD
-0.10
(-1.11%)
مغلق
حجم التداول
75,400
الربح لكل سهم
0
العائد الربحي
-
P/E
-34
حجم السوق
1,870,697,450
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
BNTX
BNTX
1.570
(1.45%)
109.800 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
R
RGEN
0.490
(0.39%)
127.440 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: BioCryst Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.